sitagliptin vs semaglutide Efficacy and safety of once-weekly versus once-daily as an add-on to metformin, thiazolidinediones, or both, in patients with type 2 diabetes (SUSTAIN 2): a 56-week, double-blind, phase 3a, randomised trial Lesson: Oral Semaglutide: A New

The eye is an immunologically privileged site with its own regulatory mechanisms, and GLP-1 receptors are expressed in ocular tissues, providing a plausible mechanism for local anti-inflammatory effects

Both medications are typically prescribed for individuals with a BMI of 30 or above, or 27 or above with weight-related health conditions such as high blood pressure, type 2 diabetes, or high cholesterol

Managing Side Effects Without Changing the Schedule If your interest in twice-weekly injections is driven by a desire to avoid nausea or fatigue, there are safer, more effective ways to manage those symptoms

GLP-1 medications have no abuse potential and no controlled substance designation

While pregnancy should be avoided on any weight loss medication, the teratogenicity risk with Qsymia (specifically topiramate causing cleft palate) is uniquely severe